The aim of this study was to investigate whether treatment with rapamycin plus vildagliptin restores beta-cell function in patients with long-standing type 1 diabetes.
Rapamycin Plus Vildagliptin to Recover ß Cell Function in Long Standing Type 1 Diabetes: A Double Blind Randomized Trial / Bolla, A.M., Gandolfi, A., Borgonovo, E., Laurenzi, A., Caretto, A., Molinari, C., Catalano, R.S., Bianconi, E., Monti, P., Sordi, V., Pellegrini, S., Lampasona, V., Costa, S., Scavini, M., Bosi, E., Piemonti, L.. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - 106:2(2021), pp. 507-519. [10.1210/clinem/dgaa791]
Rapamycin Plus Vildagliptin to Recover ß Cell Function in Long Standing Type 1 Diabetes: A Double Blind Randomized Trial
Borgonovo, Elisa;Laurenzi, Andrea;Bosi, EmanuelePenultimo
;Piemonti, Lorenzo
Ultimo
2021-01-01
Abstract
The aim of this study was to investigate whether treatment with rapamycin plus vildagliptin restores beta-cell function in patients with long-standing type 1 diabetes.| File | Dimensione | Formato | |
|---|---|---|---|
|
dgaa791.pdf
solo gestori archivio
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Tutti i diritti riservati
Dimensione
3.12 MB
Formato
Adobe PDF
|
3.12 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
